本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bicara Therapeutics

15.51
+1.6912.23%
盘后15.510.00000.00%17:52 EDT
成交量:117.58万
成交额:1,807.42万
市值:8.46亿
市盈率:-3.83
高:16.22
开:14.10
低:13.66
收:13.82
数据加载中...
2025/03/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/26

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/26

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/18

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/11

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/09/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/03

SEC问询函

Form CORRESP - Correspondence
2024/09/03

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/28

SEC问询函

Form CORRESP - Correspondence